Table 5.
Viral reactivation or infection in 46 patients post DUCBT in whom viral-specific T cell recovery was examined.
| Viral Infection type | Number of patients with incident infection |
Median days to diagnosis of infection |
Range | |
|---|---|---|---|---|
| Viremia/ DNAemia |
End organ involvement |
|||
| CMV | 19 | 8 | 31 | (13–77) |
| BKV | 9 | - | 48 | (12–97) |
| HHV6 | 2 | - | 66 | |
| Parvovirus | - | 1 | 69 | |
| Adenovirus | 2 | 3 | 70 | (44–85) |
| HSV | - | 1 | 139 | |
| EBV | - | 2 | 254 | |
| RSV | - | 1 | 425 | |
| Parainfluenza 1–3 | 1 | 3 | 455 | (98–1237) |
| Influenza B | - | 1 | 799 | |
| Total Number of incident infections | 33 | 20 | 44 | (12–1237) |
| Number of different types of viral infection / patient |
Number of patients | % |
|---|---|---|
| One | 18 | 55% |
| Two | 10 | 30% |
| Three | 5 | 15% |
| Total patients with at least 1 type of viral infection | 33 | 100% |
Abbreviations: CMV, cytomegalovirus; BKV, BK virus; EBV, Epstein Barr virus; HHV6, human herpesvirus 6; HSV, herpes simplex virus; RSV, respiratory syncytial virus